Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BBH vs. FBDIX: which is better?

Bottom line

BBH vs FBDIX: the short answer

BBH (VanEck Biotech ETF) and FBDIX (Franklin Biotechnology Discovery Fund) share a meaningful slice of their top holdings — about 40% by weight.

But FBDIX is far broader, holding 126 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.

BBH is cheaper at 0.35% vs 1.01% — a difference of $66 a year per $10,000 invested.

Over five years, FBDIX returned +5.0% a year vs +2.7% for BBH.

FBDIX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

BBH vs FBDIX side by side

BBHFBDIX
TypeETFMutual fund
Fund familyVanEckFranklin Templeton
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%1.01%
Annual cost per $10k$35$101
10-yr cost on $10k (prospectus)$443$1,728
Max front loadNone5.5%
12b-1 fee—0.25%
1-yr return+21.2%+43.9%
5-yr return (annualized)+2.7%+5.0%
10-yr return (annualized)+4.5%+6.4%
Best quarter+27.6%+29.5%
Worst quarter−18.2%−24.5%
Net assets (fund)$395.6M$1.2B
Number of holdings25126
Portfolio turnover19%38%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBBHFBDIXDifference
2025+21.2%+52.3%−31.1%
2024−4.4%+4.0%−8.4%
2023+3.9%+18.4%−14.5%
2022−15.1%−12.7%−2.5%
2021+11.8%−17.7%+29.5%
2020+22.1%+29.9%−7.8%
2019+25.8%+34.8%−9.1%
2018−10.2%−15.7%+5.5%
2017+16.6%+18.8%−2.2%
2016−15.0%−17.2%+2.1%

Source: Fund prospectus bar charts

Holdings overlap

8 of BBH's top 25 holdings also appear in FBDIX's top 25.

Shared top holdings
HoldingBBHFBDIX
Amgen Inc15.25%4.39%
Gilead Sciences Inc12.79%3.86%
Vertex Pharmaceuticals Inc9.10%3.54%
Regeneron Pharmaceuticals Inc6.21%3.77%
Revolution Medicines Inc5.27%3.01%
Argenx SE4.97%3.62%
Insmed Inc2.67%1.99%
Neurocrine Biosciences Inc2.08%1.82%

Source: SEC Form N-PORT

BBH top 10

  1. Amgen Inc — 15.25%
  2. Gilead Sciences Inc — 12.79%
  3. Vertex Pharmaceuticals Inc — 9.10%
  4. Regeneron Pharmaceuticals Inc — 6.21%
  5. Revolution Medicines Inc — 5.27%
  6. Argenx SE — 4.97%
  7. Natera Inc — 4.92%
  8. IQVIA Holdings Inc — 4.31%
  9. Alnylam Pharmaceuticals Inc — 3.83%
  10. Biogen Inc — 3.63%

FBDIX top 10

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Guardant Health, Inc. — 2.76%
  10. Ascendis Pharma A/S — 2.56%

FAQ

What is the difference between BBH and FBDIX?
BBH (VanEck Biotech ETF) and FBDIX (Franklin Biotechnology Discovery Fund) share a meaningful slice of their top holdings — about 40% by weight. But FBDIX is far broader, holding 126 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
Which is cheaper, BBH or FBDIX?
BBH has the lower expense ratio (0.35%).
Should I own both BBH and FBDIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.